troddernegi Profile Banner
Turkish Society For Radiation Oncology Profile
Turkish Society For Radiation Oncology

@troddernegi

Followers
389
Following
8
Media
433
Statuses
587

Radiating science, Radiant Future…

Joined May 2020
Don't wanna be here? Send us removal request.
@troddernegi
Turkish Society For Radiation Oncology
3 days
New study of 19 experts shows wide variability in recommending RNI for pN1(sn) early breast cancer without ALND. Consensus at extremes (high-risk: comprehensive RNI; low-risk: omit); none for mid-risk. Calls for guideline updates ✨.#BreastCancer #RadOnc
Tweet card summary image
thegreenjournal.com
Due to many randomised studies investigating different risk factors that do not always coincide, breast cancer experts rely on a wide variety of criteria to recommend RNI for pN1(sn) breast cancer,...
0
1
4
@troddernegi
Turkish Society For Radiation Oncology
4 days
✅ Safe & effective—even in high-risk epidural/paraspinal cases. #RadOnc #SBRT #Oligometastases.
0
0
1
@troddernegi
Turkish Society For Radiation Oncology
4 days
🚨 New prospective trial on dose-intensified SBRT for vertebral oligometastases (n=128, 143 lesions):.🔹 2-yr local failure: 5.3% (only 4 cases).🔹 2-yr OS: 82.2%.🔹 No ≥G4 toxicity, G3 AEs 5.5%.🔹 2-yr vertebral fracture rate: 9.8%.@Mat_Guc .
Tweet card summary image
thegreenjournal.com
Up to 70% of bone metastases are located in the vertebral spine [1] and many patients experience pain, neurological deficits, spinal instability, and pathological fractures. Conventional external...
1
0
3
@troddernegi
Turkish Society For Radiation Oncology
4 days
0
0
1
@troddernegi
Turkish Society For Radiation Oncology
4 days
The EORTC Head and Neck Cancer Group Autumn Meeting 2025 will be held in Istanbul on October 3-4. This international meeting will bring together leading researchers and clinicians to discuss the latest developments in the field of head and neck cancers.
Tweet media one
1
0
3
@troddernegi
Turkish Society For Radiation Oncology
5 days
👥 Chairperson: Felix Ehret, MD, MS.👥 Vice Chairperson: Tugce Kutuk, MD.👥 Secretary: Aseem Bhatnagar, MD.👥 Members: Jesus E. Juarez Casillas, MD, MS • Nilanjan Halder, MD • Yoonsun Jee, MD • Jayavignesh Sekar, MD. #RSSRA.
0
0
1
@troddernegi
Turkish Society For Radiation Oncology
5 days
The RSS Residents Association (RSSRA) welcomes its new Executive Committee for 2025–2026 🎉. Congratulations to Vice Chairperson Tugce Kutuk, MD 🎉🎉🎉
Tweet media one
1
1
8
@troddernegi
Turkish Society For Radiation Oncology
8 days
0
0
1
@troddernegi
Turkish Society For Radiation Oncology
8 days
📢 GETUG 14 Trial Results. In IR/HR localized #ProstateCancer, adding 4 months of ADT to 80 Gy high-dose RT improved 5-year DFS 84% vs 76% (HR 0.64) 🎯. Biochemical failure ↓ (10% vs 21%), no OS benefit, toxicity similar except ↑ early ED. #OncoTwitter #RadOnc #UroOnc.
1
0
14
@troddernegi
Turkish Society For Radiation Oncology
11 days
🎯 Upcoming Webinar Alert !. We are pleased to invite you to a free webinar organized by The Radiosurgery Society ☢️ . 📅 Thursday, August 21, 2025. 🕘 9:00 AM PT / 12:00 PM ET. 👉🏻Don’t miss this opportunity to learn from leading experts in the field !.
@the_RSS
the Radiosurgery Society
19 days
Don't miss our FREE #RSSwebinar "SBRT for the Head and Neck, Skull Base, and Reirradiation" at noon ET on 8/21 featuring @JackPhanMDPhD1 and Mustafa Cengiz, MD, moderated by @ugurselekMD. Register now at
Tweet media one
0
2
9
@troddernegi
Turkish Society For Radiation Oncology
11 days
👉🏻Key Findings:.43% routinely use NCCN guidelines.47% routinely use PSMA-PET/CT.73% recommend ADT only for unfav IR .60% prefer ultra-hypofractionated RT.97% consider cardiovascular status in decisions.💥Shift toward personalized treatment is accelerating!.
0
0
1
@troddernegi
Turkish Society For Radiation Oncology
11 days
New Publication From 🇹🇷 . National survey of ☢️ and ADT strategies with PSMA-.PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 Study. #ProstateCancer #Radiotherapy #PSMAPET #UroOncology #TROD09007.
1
0
6
@troddernegi
Turkish Society For Radiation Oncology
11 days
🔥 FLAME Trial (10-Year Update): . Focal boost to intraprostatic lesions improved 10-year bDFS from 71% to 86%, DFS from 67% to 81%, and local control from 86% to 95%, without added toxicity ⚠️ . #RadOnc #ProstateCancer #FLAMETrial.
Tweet card summary image
ascopubs.org
The FLAME trial hypothesized that focal boosting of intraprostatic tumor lesion(s) in addition to standard external beam radiotherapy (EBRT) improves biochemical disease-free survival (bDFS). In this...
0
0
4
@troddernegi
Turkish Society For Radiation Oncology
11 days
🔬 Long Term Results of RTOG 9601: . Adding 24 months of anti-androgen therapy (bicalutamide) to salvage ☢️ increased 18-year OS from 43% to 53% and reduced prostate cancer death by 10% and metastasis by 8.8%. #ProstateCancer #RadOnc #GUOnc.
Tweet card summary image
redjournal.org
Salvage radiation therapy (RT) is used in men with prostate cancer (PC) recurrence following radical prostatectomy (RP) signaled by a persistent or delayed elevation in PSA. It was previously...
0
0
2
@troddernegi
Turkish Society For Radiation Oncology
11 days
New RCT from 🇨🇳. In NPC patients receiving CRT, bacterial decolonization with mupirocin 👃🏻 ointment cut severe oral mucositis risk by half (22% vs 47%), eased pain/swallowing issues, and reduced S. Aureus colonization 🦠💊.
Tweet card summary image
jamanetwork.com
This randomized clinical trial evaluates the efficacy of bacterial decolonization with mupirocin nasal ointment in alleviating severe acute radiation oral mucositis during radiotherapy.
0
1
3
@troddernegi
Turkish Society For Radiation Oncology
11 days
📍 The results of an anticipated study (NRG-CC003). In SCLC 🫁 , hippocampal avoidance during PCI preserves intracranial control and reduces overall neurocognitive decline, despite no HVLT-R delayed recall benefit. 🧠✨.
Tweet card summary image
ascopubs.org
PURPOSEHippocampal avoidance (HA) during therapeutic whole-brain radiotherapy reduces the risk of neurocognitive function (NCF) toxicity in patients with brain metastasis. This trial hypothesized...
0
1
6
@troddernegi
Turkish Society For Radiation Oncology
11 days
New study alert 🔔 . NRG BN007. 👥 MGMT-unmethylated glioblastoma. RT+Tmz 🆚 RT+Nivo/Ipi. PFS: Similar between groups 🚫. ✍🏻 In this challenging patient population, current evidence shows that even dual ICI therapy offers no meaningful benefit.
0
0
4
@troddernegi
Turkish Society For Radiation Oncology
11 days
RT @EUplatinum: 📢 New in European Urology:.SABR is not just for brain mets. A systematic review shows excellent results in RCC—alone or wit….
0
46
0
@troddernegi
Turkish Society For Radiation Oncology
18 days
🌍 Bridging innovation and context, equity and excellence. 🗓️ Mark your calendars and stay tuned for the full program, abstract submissions, and registration details. #XIOM2025 #Oncology #GlobalHealth #CancerCare #LMIC #TROD #RadiationOncology #CancerControl #SaveTheDate
Tweet media one
0
0
2